Work · Healthtech

Turning a legacy
Plan page into Voy's Treatment Hub

I led the redesign of one of Voy's most complex product surfaces, transforming a static subscription management page into a scalable Treatment Hub designed around retention, self-service and multi-product growth.

Lead Product Designer · Strategy · UX/UI · Validation & rollout

+11pp

More patients self-served

-21%

Fewer support contacts

3.1pp

Higher cross-sell attach

+2.3pp

Higher 30 day retention

A redesign brief became a bigger product opportunity

Context

The original ask was simple: modernise an outdated Plan page.

But the existing experience had bigger problems. It had grown organically across multiple teams, creating duplicated actions, unclear hierarchy and an increasingly difficult codebase.

Patients were also struggling with basic questions

  • What treatment am I on?

  • When am I paying next?

  • When will it arrive?

  • How do I change something?

The Reframe

How might we rebuild the Plan page into a Treatment Hub that helps patients stay on treatment, stay in control and discover the right support next?

That opened up three opportunities

01

Reduce avoidable friction

Make high-frequency actions like changing dose, moving an order and pausing immediately accessible.

02

Drive ongoing retention

Surface the right intervention before uncertainty, plateaus or treatment issues become reasons to leave.

03

Unlock multi-product growth

Create a scalable place for patients to manage and discover treatments, products and services across Voy.

— Evidence

I started with the evidence

I combined PX and Joy escalation data, customer feedback, interviews, surveys and behavioural data with a full teardown of the existing experience. Four themes stood out.


Basic self-service was too difficult

Actions patients regularly needed were buried amongst a long list of competing modules. Moving an order, changing dose or switching treatment could easily become a support interaction.


The next order created anxiety

Patients wanted three things to be immediately obvious: what am I getting, what will I pay, and when will it arrive? The existing experience didn't answer them clearly enough.


Every patient saw essentially the same page

Month one and month six are completely different moments in treatment. Yet the experience treated them almost identically.


The product couldn't scale with Voy

The architecture assumed one treatment and one category, a problem as Voy expanded into hair loss, menopause, TRT, new products and new markets.

— Principles

Three principles turned those insights into direction

Make key actions obvious

Give patients immediate control over the things that keep treatment working around real life. Less friction means fewer support contacts, and fewer avoidable reasons to churn.

Guide patients to stay on track

Move away from a static page and surface the support most relevant to the patient's stage of treatment, shifting the product from “manage my subscription” to “help me keep progressing.”

Recommend trusted support

Cross-sell should feel like care, not advertising. Rather than showing everyone the same products, the Treatment Hub creates space for recommendations based on treatment, progress and need.

  • Nutrition support when appetite is low.

  • A blood test when someone wants deeper health insight.

  • Another Voy treatment when it is genuinely relevant.

— Direction

Looking outside healthcare unlocked the design

Direct competitors mostly treated treatment management as a long list of cards. Wanting to simplify far more aggressively, I looked outside healthcare at Monzo, Revolut and Wise, products that make complex financial systems feel remarkably simple. Three patterns shaped the direction.

Pattern 01

Make status unmistakable

The customer should immediately understand what they have and what is happening next.

Pattern 02

Put actions beside the thing they affect

Treatment management belongs around the treatment — not scattered across a page.

Pattern 03

Reveal complexity progressively

Prioritise what matters now rather than exposing every possible action upfront.

— The Design

From feature list to treatment-first experience

The biggest shift was changing the organising principle of the page. Instead of asking where should Pause go? Where should dose change go? Where should cross-sell go? I asked

What does this patient need to know or do with their treatment right now?

Treatment becomes the hero

The medication anchors the experience and immediately communicates the patient's current treatment.

Key actions sit directly beneath it

Change dose · Move order · Manage

The highest-value actions are always close at hand.

The next order answers the important questions

Next dose · Confirm by · Price

No hunting through multiple cards.

Care becomes contextual

Treatment optimisation, switching, clinical support and other interventions appear when they become relevant.

Additional Voy products fit naturally underneath

Products and treatments are recommended within the context of care rather than added as generic shop modules.

Making treatment feel worth celebrating

There was also an emotional opportunity. GLP-1 medication has historically carried stigma, and I wanted Voy to present treatment as something that can create meaningful change in someone's life.

I worked with a 3D designer to make the medication itself the visual centrepiece, tangible, premium and positive, rather than something hidden inside an administrative interface. The same visual system scales across future injections, pills and treatment categories.

— Journey

Designing for the journey, not just the screen

The Treatment Hub was designed to evolve with the patient, so the support on offer matches the moment they're in.

  • Early treatment

    Getting started · Confidence · Dose understanding · Side-effect support

  • Progressing

    Dose optimisation · Progress reinforcement · Treatment review

  • Longer term

    Plateau support · Switching · Maintenance · Longer plans

— Systems & ownership

The complexity behind a simple screen

The simplicity of the UI hides a much more complicated product system. The existing page carried years of accumulated behaviour

I worked closely with engineers and PMs to map that architecture before replacing it, and ran workshops with the teams behind orders, pause and treatment management to understand their constraints and make sure the new experience could genuinely replace the old one. The goal wasn't a better happy path, it was a system robust enough to become the foundation for future treatment management.

Leading a shared surface

The biggest challenge wasn't design, it was ownership. Many teams had functionality living on the Plan page, but nobody owned the experience as a whole. I became the design lead and connective point: setting the product vision, running cross-functional workshops, aligning priorities with PM and engineering, working with Clinical and PX on constraints and evidence, partnering with specialist designers on motion, and regularly presenting the direction to senior leadership and C-suite stakeholders.

The patient journey and JTDB became the framework for deciding what earned space, rather than which team happened to own a feature.

— Rollout & results

Validated carefully, then scaled

Because this is one of the most operationally sensitive areas of the app, we avoided a big-bang launch.

Step 1

Usability testing

Validate the new hierarchy and treatment-management model.

Step 2

Internal + PX feedback

Pressure-test against the issues customers raise every day.

Step 3

Controlled rollout

Release progressively and monitor customer behaviour.

Step 4

Scale

Use the architecture as the foundation for more categories and markets.

Impact

+11pp

Self-service completion

68% → 79% of patients completed key treatment tasks themselves, without needing support.

+3.1pp

Cross-sell attach

11.1% → 14.2% of patients added another Voy product after seeing a relevant recommendation.

−21%

Support contacts

Fewer patients contacted PX about orders, delivery, dose changes or managing treatment.

+2.3pp

30-day retention

Patients using the new Treatment Hub were more likely to still be on treatment 30 days later.

Beyond the numbers, we created a new product surface for retention, a foundation for

Self-service

Resolving common treatment needs without contacting support.

Longer plans

Contextual moments to encourage longer-term treatment.

Multi-treatment customers

Multiple Voy treatments inside one coherent model.

Retention interventions

Surfacing help before uncertainty or plateaus become churn.

Cross-sell

Relevant Voy products recommended within the care journey.

International scale

Reusable architecture for markets including Germany and Brazil.